MedTrace Logo

Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin

NCT00276419 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2012-12-20

Study results available
· View outcomes & findings →

Summary

The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.

Conditions

  • Breast Pain
  • Non-cyclical Mastalgia
  • Surgical Scar-Related Breast Pain

Interventions

DRUG

Diclofenac

Compounded topical diclofenac cream applied to the skin three times daily for 10 weeks

DRUG

Placebo

Placebo for Diclofenac in topical cream applied to the skin three times daily for 10 weeks

Sponsors & Collaborators

Principal Investigators

  • Robin L. Smith, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00276419 on ClinicalTrials.gov